Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment    

Global General & Plastic Surgery Market

PRODUCT TITLE PUBLISHED
European Radiofrequency Ablation European Radiofrequency Ablation
The European Radiofrequency Ablation Market was pegged at $1160 million in 2013 and expected to be $2313 million by 2018. The key players in European radiofrequency ablation therapy sector are Covidien (Ireland), Boston Scientific (U.S.), Biosense Inc. (U.S.), St. Jude Medical (U.S.), AngioDynamics (U.S.) and Medtronic Inc. (U.S.).
Upcoming
Americas Ultrasound Ablation Americas Ultrasound Ablation
The American Ultrasound Ablation Market was pegged at $644 million in 2013 and expected to be $1155 million by 2018. The key players in ultrasound ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix.
Upcoming
Asia-Pacific Ultrasound Ablation Asia-Pacific Ultrasound Ablation
The Asia-Pacific Ultrasound Ablation Market was pegged at $259 million in 2013 and expected to be $535 million by 2018. The key players in Asia-Pacific Ultrasound Ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix.
Upcoming
European Ultrasound Ablation European Ultrasound Ablation
The European Ultrasound Ablation Market was pegged at $286 million in 2013 and expected to be $500 million by 2018. The key players in European Ultrasound Ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix.
Upcoming
Americas Thermal Ablation Americas Thermal Ablation
The American Thermal Ablation Market was pegged at $3097 million in 2013 and expected to be $5012 million by 2018. The main companies operating in thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others
Upcoming
Asia-Pacific Thermal Ablation Asia-Pacific Thermal Ablation
The Asia-Pacific Thermal Ablation Market was pegged at $1533 million in 2013 and expected to be $2772 million by 2018. The main companies operating in Asia-Pacific Thermal Ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.
Upcoming
European Thermal Ablation European Thermal Ablation
The European Thermal Ablation Market was pegged at $2132 million in 2013 and expected to be $3328 million by 2018. The main companies operating in European thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others.
Upcoming
Americas Electrical Ablators Americas Electrical Ablators
The electrical ablation market of the Americas, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $387 million in 2013 and is expected to reach $480 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland).
Upcoming
Asia-Pacific Electrical Ablators Asia-Pacific Electrical Ablators
The Asia-Pacific electrical ablator market, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $159 million in 2013 and is expected to reach $236 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland).
Upcoming
European Electrical Ablators European Electrical Ablators
The European electrical ablator market, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $189 million in 2013 and is expected to reach $228 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland).
Upcoming
European Brachytherapy European Brachytherapy
The European Brachytherapy Market was pegged at $50 million in 2013 and expected to be $54 million by 2018. The report “European Brachytherapy Market forecast, 2010-2018 “analyzes the market of devices by segments such as High Dose Rate Brachytherapy, Pulsed Dose Rate Brachytherapy, and Permanent Seed Brachytherapy. The main companies operating in European Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
Asia-Pacific Brachytherapy Asia-Pacific Brachytherapy
The Asia-Pacific Radiation Ablation Market was pegged at $32 million in 2013 and expected to be $38 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. The main companies operating in Asia-Pacific brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
Americas Brachytherapy Americas Brachytherapy
The American Brachytherapy Market was pegged at $129 million in 2013 and expected to be $146 million by 2018. Brachytherapy involves the implantation of radioactivity within the body to ablate or kill cancer or tumour cells within or in close proximity to the target area in the body. The main companies operating in Brachytherapy market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden).
Upcoming
North America Intrauterine Contraceptive Devices North America Intrauterine Contraceptive Devices
The growth of the intrauterine contraceptive devices market is driven by various factors, such as the rising rate of unplanned pregnancies, effective contraception and minimum side effects of IUCD, implementation of the Affordable Care Act (ACA), higher number of initiatives undertaken by private firms directed towards reducing the expenses related to abortion, and the various technological advancements.
Feb 2015
Intrauterine Contraceptive Devices Intrauterine Contraceptive Devices
Intrauterine Contraceptive Devices and Facial Aesthetics Devices,
Apr 2015
Europe Stationary cycles Europe Stationary cycles
The major drivers of the European stationary cycle market include the increasing number of diabetes and cardiac patients; increasing personal disposable incomes; and government initiatives to increase health and fitness awareness. For instance, in Italy, the government issued a plan for the prevention of obesity. The plan includes actions such as breastfeeding promotion, eating habits improvement, enhancing physical activity at schools and workplaces, and promotion and facilitation of physical activity in the urban areas.
Feb 2015
North American Stationary cycles North American Stationary cycles
Stationary cycles - North America constitute 0.5% of Global Stationary cycles market and are poised to grow its market share to 0.4% by the end of year 2019. It is segmented on basis of .   What makes our report unique? You...
Feb 2015
Asian Stationary cycles Asian Stationary cycles
Stationary cycles - Asia constitute 0.0% of Global Stationary cycles market and are poised to grow its market share to 0.0% by the end of year 2019. It is segmented on basis of .   What makes our report unique? You can...
Apr 2015
Hernia Mesh Hernia Mesh
Peers of Hernia Mesh are Weight Loss & Obesity Management, Ablation Devices, Facial Aesthetics Devices and Intrauterine Contraceptive Devices comprising respectively of the Global General Surgery Devices market. It is segmented on basis of . ...
Upcoming
North America Hernia Mesh North America Hernia Mesh
The North America hernia mesh market is expected to register a CAGR of 1.8% between 2016 and 2021. The Synthetic mesh segment and biological mesh segment both accounted for the largest share; i.e. 50% of the overall hernia mesh market in 2015. Synthetic mesh segment is expected to grow at a CAGR of 0.4% for the forecast period from 2016-2021. 
Upcoming
105 reports | Show
Connect With Us
US/CAN : +1-888-502-0539